The relative metal release protocol serves as a vital tool for evaluating the toxicity of metal-containing materials. It specifically measures how metal ions dissolve in surrogate gastric fluid, which effectively simulates human oral exposure routes. Since 2010, the metals industry has refined this method to improve accuracy and regulatory compliance across various substances. Consequently, these advancements help identify matrix effects in complex materials that might otherwise skew toxicity predictions.

Advances in the Relative Metal Release Protocol

Moreover, the recently updated 2025 version of the protocol provides significant improvements in clarity and method robustness. Reviewers from global organizations like the OECD and EURL ECVAM have scrutinized the method over the last fifteen years. Consequently, the revised protocol now offers a more reliable framework for grouping and read-across strategies. These strategies are essential because they contribute to a substantial reduction in animal testing for human health toxicity classification.

Furthermore, the protocol is highly relevant for substances regulated under frameworks like EU REACH. By accurately predicting ion release from massive or powder forms of alloys, scientists can refine classifications based on real-world bioaccessibility. Therefore, this evolution represents a major step forward in both regulatory science and ethical research practices. Notably, the 2025 version is now publicly accessible via the TSAR database for global use.

Frequently Asked Questions

How does the protocol simulate human digestion?

The method uses a surrogate gastric fluid composed of hydrochloric acid at a pH of 1.5. This environment mimics the acidic conditions of the human stomach to measure how much of a metal substance dissolves after oral ingestion.

What are the regulatory benefits of this method?

It supports grouping and read-across, allowing regulators to predict the toxicity of similar materials without new animal trials. Additionally, it helps identify matrix effects where the combination of metals in an alloy changes the release rate of toxic ions.

Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

• Oller AR et al. Tracing progress: The evolution of a protocol for relative metal release in surrogate gastric fluid. ALTEX. 2026 Apr 20. doi: 10.14573/altex.2512181. PMID: 42010952.


• European Commission. Bioaccessibility testing (Bioelution) of metals, inorganic metals compounds and metals-containing materials: simulated gastric fluid. TSAR - Tracking System for Alternative methods towards Regulatory acceptance. 2025.